Welcome.AIWelcome.AI
    Skip to content

    Accurx and Tandem Partnership Strengthens HealthTech Positioning in NHS

    Discover how Accurx Scribe, powered by Tandem, became the NHS's fastest scaling ambient AI scribe, transforming clinician workflows and setting new benchmarks for HealthTech partnerships in Europe.

    healthcare.digitalSeptember 19, 20261 min read

    Key Facts

    • Accurx's 25 Trust contracts signal strong market positioning ahead of NHS funding influx.
    • Tandem's $100M funding reflects investor confidence in UK market access via Accurx partnership.
    • Accurx's integration with EPRs offers a competitive edge over standalone scribe vendors.
    • NHS's AVT registry legitimizes ambient scribing, creating a barrier for new entrants in HealthTech.
    • Strategic partnership allows both firms to focus on core strengths, enhancing product development speed.

    Summary

    Summary

    Accurx, a London-based communications platform, partnered with Tandem, a Stockholm AI company, to deploy Accurx Scribe, an ambient AI scribe, within the NHS. The collaboration addressed the challenge of clinical documentation efficiency, resulting in 25 Trust-wide contracts and significant time savings for clinicians.

    Background

    Accurx operates in the HealthTech industry and is utilized by 98% of GP practices in England, serving over 200,000 NHS staff. Before the deployment of Accurx Scribe, the company primarily functioned as a messaging tool, lacking advanced documentation capabilities that could enhance clinical workflows.

    Challenge

    The primary challenge was the need for an efficient solution to streamline clinical documentation processes within the NHS, as clinicians faced significant time constraints and administrative burdens during patient consultations.

    Solution

    Accurx integrated Tandem's ambient AI scribe into its existing platform, allowing clinicians to capture consultations seamlessly. This included features for speech capture, transcription, summarization, and document generation, all accessible through the familiar Accurx interface already in use by clinicians.

    Results

    Within 16 months of launch, Accurx Scribe secured 25 Trust-wide contracts, with a pipeline of pilots and proofs of concept expected to convert as funding became available. In a pilot program across University Hospitals of Leicester and University Hospitals of Northamptonshire, clinicians saved approximately eight minutes of documentation time per patient and around one hour of administrative time each day.

    Key Insights

    Successful partnerships in regulated markets require clear division of responsibilities, alignment with customer buying behavior, and readiness for regulatory compliance. Speed to market can be more valuable than complete ownership of technology, and framing solutions as infrastructure replacements can unlock larger contracts.

    Customer Testimonial

    No direct quote is available from the source material.

    Entities Mentioned

    Companies

    Accurx
    Tandem
    EQT
    Kinnevik
    Northzone
    Amino Collective
    Microsoft

    Products

    Accurx Scribe
    ambient AI scribe

    Technologies

    ambient voice technology
    speech capture
    transcription
    summarisation
    document generation

    People

    Lukas Saari

    Organizations

    NHS
    NHS England
    University Hospitals of Leicester
    University Hospitals of Northamptonshire

    Key Concepts

    strategic partnerships
    ambient voice technology
    clinical safety
    NHS procurement
    market timing
    distribution advantage
    regulatory compliance
    clinical workflow integration

    Definitions

    ambient voice technology
    A technology that captures and transcribes spoken language in clinical settings, facilitating documentation and communication.
    EPR
    Electronic Patient Record, a digital version of a patient's paper chart that contains the medical and treatment history of the patients.
    DTAC
    Digital Technology Assessment Criteria, a framework for assessing digital health technologies in the NHS.
    clinical safety evidence
    Documentation and data that demonstrate the safety and efficacy of clinical products and technologies.
    procurement
    The process of acquiring goods and services, particularly in the context of public sector organizations like the NHS.

    Use Cases

    • embedding ambient AI scribe into existing products
    • capturing clinical consultations
    • generating clinical documents and letters
    • integrating with clinical record systems
    • improving clinician workflow efficiency
    • managing patient communications

    Frequently Asked Questions

    What is Accurx Scribe?

    Accurx Scribe is an ambient AI scribe integrated into the Accurx communications platform, designed to streamline clinical documentation by capturing and transcribing consultations.

    How does the partnership between Accurx and Tandem benefit both companies?

    The partnership allows Accurx to leverage Tandem's advanced AI technology while providing Tandem access to a vast network of NHS clinicians, enhancing both companies' market reach and product offerings.

    What are the key advantages of using ambient voice technology in healthcare?

    Ambient voice technology improves documentation efficiency, reduces clinician workload, and enhances patient care by allowing healthcare professionals to focus more on patient interactions rather than administrative tasks.

    What challenges do Accurx and Tandem face in the NHS market?

    Both companies face challenges such as regulatory compliance, integration with existing EPR systems, and competition from larger incumbents like Microsoft and other EPR vendors.

    How does regulatory compliance impact the deployment of Accurx Scribe?

    Regulatory compliance ensures that Accurx Scribe meets safety and efficacy standards, which is crucial for gaining trust from NHS Trusts and securing contracts for deployment.

    Where AI Leaders Stay Informed

    The latest AI intelligence, case studies, and research — delivered to your inbox every week.

    Free to read. Unsubscribe anytime.